Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer
DOI:
10.2147/ceor.s489783
Publication Date:
2024-10-19T02:30:12Z
AUTHORS (3)
ABSTRACT
This study aimed to estimate the costs associated with adverse events (AEs) in advanced lung cancer patients treated first-line therapies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....